Open AccessImmunomodulatory treatments for relapsing–remitting multiple sclerosis
Author(s) -
Fritz Leutmezer
Publication year - 2017
Publication title -
hamdan medical journal
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2227-247X
pISSN - 2227-2437
DOI - 10.7707/hmj.806
Subject(s) - multiple sclerosis , medicine , tolerability , clinical trial , relapsing remitting , disease , intensive care medicine , glatiramer acetate , adverse effect , pharmacology , immunology